Your browser doesn't support javascript.
loading
GPIHBP1 autoantibody syndrome during interferon ß1a treatment.
Eguchi, Jun; Miyashita, Kazuya; Fukamachi, Isamu; Nakajima, Katsuyuki; Murakami, Masami; Kawahara, Yuko; Yamashita, Toru; Ohta, Yasuyuki; Abe, Koji; Nakatsuka, Atsuko; Mino, Mai; Takase, Satoru; Okazaki, Hiroaki; Hegele, Robert A; Ploug, Michael; Hu, Xuchen; Wada, Jun; Young, Stephen G; Beigneux, Anne P.
Afiliação
  • Eguchi J; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
  • Miyashita K; Immuno-Biological Laboratories (IBL) Co., Ltd., Fujioka, Gunma, Japan; Department of Clinical Laboratory Medicine, Gunma University, Graduate School of Medicine, Maebashi, Japan.
  • Fukamachi I; Immuno-Biological Laboratories (IBL) Co., Ltd., Fujioka, Gunma, Japan.
  • Nakajima K; Department of Clinical Laboratory Medicine, Gunma University, Graduate School of Medicine, Maebashi, Japan.
  • Murakami M; Department of Clinical Laboratory Medicine, Gunma University, Graduate School of Medicine, Maebashi, Japan.
  • Kawahara Y; Department of Neurology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
  • Yamashita T; Department of Neurology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
  • Ohta Y; Department of Neurology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
  • Abe K; Department of Neurology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
  • Nakatsuka A; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
  • Mino M; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
  • Takase S; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Okazaki H; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Hegele RA; Department of Medicine and Robarts Research Institute, Western University, London, Ontario, Canada.
  • Ploug M; Finsen Laboratory, Rigshospitalet, Copenhagen N, Denmark; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.
  • Hu X; Departments of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Wada J; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan. Electronic address: junwada@okayama-u.ac.jp.
  • Young SG; Departments of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; Departments of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: sgyoung@mednet.ucla.edu.
  • Beigneux AP; Departments of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: abeigneux@mednet.ucla.edu.
J Clin Lipidol ; 13(1): 62-69, 2019.
Article em En | MEDLINE | ID: mdl-30514621
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Interferon beta / Receptores de Lipoproteínas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Hiperlipoproteinemia Tipo I / Esclerose Múltipla Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans Idioma: En Revista: J Clin Lipidol Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Interferon beta / Receptores de Lipoproteínas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Hiperlipoproteinemia Tipo I / Esclerose Múltipla Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans Idioma: En Revista: J Clin Lipidol Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão